Boston Partners’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,667
Closed -$1.44M 770
2024
Q3
$1.44M Buy
23,667
+42
+0.2% +$2.49K ﹤0.01% 556
2024
Q2
$1.37M Buy
23,625
+8,105
+52% +$416K ﹤0.01% 547
2024
Q1
$819K Buy
15,520
+5,681
+58% +$286K ﹤0.01% 610
2023
Q4
$488K Sell
9,839
-3,760
-28% -$169K ﹤0.01% 613
2023
Q3
$608K Buy
13,599
+1,025
+8% +$45.8K ﹤0.01% 613
2023
Q2
$584K Buy
12,574
+5,396
+75% +$236K ﹤0.01% 605
2023
Q1
$313K Buy
7,178
+2,703
+60% +$134K ﹤0.01% 648
2022
Q4
$223K Buy
+4,475
New +$213K ﹤0.01% 665
2019
Q1
Sell
-40,055
Closed -$1.47M 736
2018
Q4
$1.47M Sell
40,055
-18,459
-32% -$866K ﹤0.01% 601
2018
Q3
$3.43M Buy
58,514
+22,090
+61% +$1.41M ﹤0.01% 530
2018
Q2
$2.38M Sell
36,424
-4,058
-10% -$252K ﹤0.01% 623
2018
Q1
$2.37M Buy
+40,482
New +$2.74M ﹤0.01% 625

Other funds holding SRCL

Boston Partners's SRCL Position: Q4 2024 in Review

Boston Partners sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 23,667 shares — an estimated $1.44M sold.

Boston Partners first reported a position in SRCL in Q1 2018 and held it in 12 quarters. The position peaked at $3.43M in Q3 2018. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Boston Partners reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Boston Partners sold 23,667 Stericycle Inc shares in Q4 2024, an estimated $1.44M.
  • Boston Partners first reported a position in Stericycle Inc in Q1 2018 and held it in 12 quarters.
  • Boston Partners's Stericycle Inc position peaked at $3.43M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Boston Partners's 13F filing for Q4 2024, filed 11 Feb 2025.